Similar articles

• Chemotherapy sensitivity and response assays: are the ASCO guidelines for clinical trial design too restrictive?

  Wieand HS. Wieand HS. J Clin Oncol. 2005 May 20;23(15):3643-4; author reply 3646-8. doi: 10.1200/JCO.2005.05.321. J Clin Oncol. 2005. PMID: 15908687 No abstract available.
• In vitro drug resistance versus chemosensitivity: two sides of different coins.

  Fruehauf JP, Alberts DS. Fruehauf JP, et al. J Clin Oncol. 2005 May 20;23(15):3641-3; author reply 3646-8. doi: 10.1200/JCO.2005.05.281. J Clin Oncol. 2005. PMID: 15908686 Review. No abstract available.
• Developing new agents for the treatment of childhood cancer.

  Kurmasheva R, Morton C, Houghton PJ. Kurmasheva R, et al. Curr Opin Investig Drugs. 2005 Dec;6(12):1215-27. Curr Opin Investig Drugs. 2005. PMID: 16372407 Review.
• Practical guidelines for diagnostic use of in vitro chemosensitivity tests.

  Schinköthe T, Haeger S, Gabri MR. Schinköthe T, et al. Anticancer Res. 2007 May-Jun;27(3A):1365-7. Anticancer Res. 2007. PMID: 17593632
• [Cancer chemotherapy; past, present and future--from the aspect of fundamental studies].

  Tukagoshi S. Tukagoshi S. Gan To Kagaku Ryoho. 2003 Oct;30(10):1398-403. Gan To Kagaku Ryoho. 2003. PMID: 14584271 Review. Japanese.